Iu.O. Panchenko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Iu.O. Panchenko has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- A.O. Gulida
SHUPYK NATIONAL HEALTHCARE UNIVERSITY OF UKRAINE, KYIV, UKRAINE
5 shared publications - M.I. Kovtun
SHUPYK NATIONAL HEALTHCARE UNIVERSITY OF UKRAINE, KYIV, UKRAINE
3 shared publications - Zoya Fedorovna Veselovskaya
Kyiv Medical University, Kyiv, Ukraine
3 shared publications - B.B. Zhupan
SHUPYK NATIONAL HEALTHCARE UNIVERSITY OF UKRAINE, KYIV, UKRAINE
2 shared publications - I. V. Verbytskyi
SHUPYK NATIONAL HEALTHCARE UNIVERSITY OF UKRAINE, KYIV, UKRAINE
2 shared publications - Pavel A. Bezditko
Kharkiv National Medical University, Kharkiv, Ukraine
2 shared publications
Latest Publications
- Open Access
- 27 June 2026
- Published by Publishing House Zaslavsky in Archive of Ukrainian Ophthalmology
- Vol. 14 (2) , 125-132
Long-term results of a multistage treatment for secondary neovascular glaucoma and proliferative diabetic retinopathy with type 2 diabetes mellitus
Background. Secondary neovascular glaucoma (NVG) is a consequence of severe chronic retinal ischemia that triggers a cascade of angiogenic factors. NVG in patients with proliferative diabetic retinopathy (PDR) and type 2 diabetes is caused by a complex combination of systemic metabolic disorders and local ischemic processes in the retina and other anatomical structures of the eye. The development of modern and safe methods for treating NVG is a pressing task. Objective: to investigate long-term outcomes of a multistage treatment for NVG with PDR and type 2 diabetes. Materials and methods. The study included 68 patients (68 eyes) with PDR, NVG, and type 2 diabetes, divided into two observation groups. Group 1 (35 patients, 35 eyes) underwent staged treatment: stage I — intravitreal injection of an anti-VEGF agent; stage II, performed 5–7 days later — phacoemulsification with monofocal intraocular lens implantation and 25-gauge closed subtotal vitrectomy (CSV) with the stage of panretinal photocoagulation and 18% C3F8 endotamponade; stage III — one month after CSV, transscleral cyclophotocoagulation (CPC) in micropulse mode. Patients in the second group (33 patients, 33 eyes) underwent staged treatment as well: stage I — anti-VEGF therapy; stage II, performed 5–7 days later — phacoemulsification with intraocular lens implantation and 25-gauge CSV with the stage of panretinal photocoagulation and endotamponade using silicone oil (5700 cSt); stage III, performed one month after CSV — CPC in a micropulse mode. Results. One year after completion of stage III, patients showed stabilization of both PDR and NVG. Normalization of intraocular pressure was achieved with topical hypotensive monotherapy in 62.9 % of cases in group 1. In group 2, disease stabilization at one year was also noted, with intraocular pressure normalized in 54.6 % of patients. In 11 indiciduals (33.4 %), silicone oil was not removed due to the high risk of recurrent vitreous hemorrhage, tractional retinal detachment, and progression of the proliferative process. In group 1, PDR progression (25.7 ± 7.4 %), recurrent vitreous hemorrhage and macular edema (22.9 ± 7.1 % each) were most frequently recorded. In group 2, ocular hypertension (45.5 ± 8.7 %), PDR progression (30.3 ± 8.0 %), retinal and preretinal hemorrhages (27.3 ± 7.8 %) were observed most often. No statistically significant differences were found between the groups regarding the incidence of hypertension, indolent uveitis, hyphema, retinal and preretinal hemorrhages, diabetic macular edema and progression of PDR (p > 0.05). Recurrent vitreous hemorrhage was observed only in group 1 — 22.9 ± 7.1 % while it was not recorded in group 2; this difference was statistically significant (p = 0.005). Conclusions. 1. The advanced treatment methods for NVG in patients with PDR and type 2 diabetes proved effective and safe over a one-year follow-up period, achieving intraocular pressure normalization in 62.9 % of group 1 patients and 54.6 % of group 2 patients. 2. Micropulse transscleral CPC, used as the third stage of NVG treatment in PDR, served as an alternative to fistulizing procedures and surgical interventions involving drainage and valve devices, without the drawbacks and complications associated with these methods on long-term follow-up. 3. Additional micropulse CPC, performed when intraocular pressure normalization was not achieved, did not cause complications, adverse effects, or patient dissatisfaction.
- 27 June 2026
- Published by Publishing House Zaslavsky in Archive of Ukrainian Ophthalmology
- Vol. 14 (2) , 125-132
Open AccessLong-term results of a multistage treatment for secondary neovascular glaucoma and proliferative diabetic retinopathy with type 2 diabetes mellitus
Background. Secondary neovascular glaucoma (NVG) is a consequence of severe chronic retinal ischemia that triggers a cascade of angiogenic factors. NVG in patients with proliferative diabetic retinopathy (PDR) and type 2 diabetes is caused by a complex combination of systemic metabolic disorders and local ischemic processes in the retina and other anatomical structures of the eye. The development of modern and safe methods for treating NVG is a pressing task. Objective: to investigate long-term outcomes of a multistage treatment for NVG with PDR and type 2 diabetes. Materials and methods. The study included 68 patients (68 eyes) with PDR, NVG, and type 2 diabetes, divided into two observation groups. Group 1 (35 patients, 35 eyes) underwent staged treatment: stage I — intravitreal injection of an anti-VEGF agent; stage II, performed 5–7 days later — phacoemulsification with monofocal intraocular lens implantation and 25-gauge closed subtotal vitrectomy (CSV) with the stage of panretinal photocoagulation and 18% C3F8 endotamponade; stage III — one month after CSV, transscleral cyclophotocoagulation (CPC) in micropulse mode. Patients in the second group (33 patients, 33 eyes) underwent staged treatment as well: stage I — anti-VEGF therapy; stage II, performed 5–7 days later — phacoemulsification with intraocular lens implantation and 25-gauge CSV with the stage of panretinal photocoagulation and endotamponade using silicone oil (5700 cSt); stage III, performed one month after CSV — CPC in a micropulse mode. Results. One year after completion of stage III, patients showed stabilization of both PDR and NVG. Normalization of intraocular pressure was achieved with topical hypotensive monotherapy in 62.9 % of cases in group 1. In group 2, disease stabilization at one year was also noted, with intraocular pressure normalized in 54.6 % of patients. In 11 indiciduals (33.4 %), silicone oil was not removed due to the high risk of recurrent vitreous hemorrhage, tractional retinal detachment, and progression of the proliferative process. In group 1, PDR progression (25.7 ± 7.4 %), recurrent vitreous hemorrhage and macular edema (22.9 ± 7.1 % each) were most frequently recorded. In group 2, ocular hypertension (45.5 ± 8.7 %), PDR progression (30.3 ± 8.0 %), retinal and preretinal hemorrhages (27.3 ± 7.8 %) were observed most often. No statistically significant differences were found between the groups regarding the incidence of hypertension, indolent uveitis, hyphema, retinal and preretinal hemorrhages, diabetic macular edema and progression of PDR (p > 0.05). Recurrent vitreous hemorrhage was observed only in group 1 — 22.9 ± 7.1 % while it was not recorded in group 2; this difference was statistically significant (p = 0.005). Conclusions. 1. The advanced treatment methods for NVG in patients with PDR and type 2 diabetes proved effective and safe over a one-year follow-up period, achieving intraocular pressure normalization in 62.9 % of group 1 patients and 54.6 % of group 2 patients. 2. Micropulse transscleral CPC, used as the third stage of NVG treatment in PDR, served as an alternative to fistulizing procedures and surgical interventions involving drainage and valve devices, without the drawbacks and complications associated with these methods on long-term follow-up. 3. Additional micropulse CPC, performed when intraocular pressure normalization was not achieved, did not cause complications, adverse effects, or patient dissatisfaction.
- Open Access
- 27 June 2026
- Published by Publishing House Zaslavsky in Archive of Ukrainian Ophthalmology
- Vol. 14 (2) , 117-124
Features of vitreoretinal surgery for idiopathic epiretinal membranes
Background. Idiopathic epiretinal membranes (ERM) are among the most common disorders of the vitreomacular interface and are one of the leading causes of reduced central vision in older patients. According to recent studies, the prevalence of ERM ranges from 7 to 39 %. With the aging of the population, the number of patients with symptomatic ERMs continues to increase, highlighting the high medical and social significance of this condition and the need to improve current treatments. Objective: to investigate the efficacy of contemporary combined and two-stage surgical approaches for the treatment of epiretinal membranes associated with age-related cataract. Materials and methods. The study included 150 patients (150 eyes) with ERM and initial age-related cataract, who were divided into two study groups. The mean age of the participants was 61.0 ± 2.3 years. In group 1 (81 eyes), 25-gauge closed subtotal vitrectomy (CSV) with ERM peeling was performed, followed by phacoemulsification 3 months later. In group 2 (69 eyes), CSV with combined ERM/internal limiting membrane (ILM) peeling was performed simultaneously with phacoemulsification and intraocular lens implantation. All patients underwent optical coherence tomography of the macular region, which was used to determine central retinal thickness, assess morphological changes in the macula, and detect the presence of an epiretinal membrane. Examinations were performed before surgery and at 1, 3, 6, and 12 months postoperatively. Results. Phacoemulsification in combination with vitreoretinal surgery is associated with a higher incidence of macular edema in the early postoperative period. However, these changes were transient; their incidence decreased significantly after 3 months, and at one year, clinically significant macular edema was absent in all patients, regardless of the type of surgical intervention. This indicates a favorable long-term prognosis for both surgical approaches. Conclusions. Our studies demonstrated that CSV with ERM peeling only and CSV with combined ERM/ILM peeling, performed either without or with simultaneous cataract surgery, are effective methods for the treatment of ERM and result in improved visual function over a 1-year follow-up period. Phacoemulsification did not significantly improve visual acuity and, conversely, was associated with a higher incidence of persistent macular edema at 1 and 3 months postoperatively. ILM peeling did not improve functional outcomes after ERM surgery but reduced the risk of ERM recurrence.
- 27 June 2026
- Published by Publishing House Zaslavsky in Archive of Ukrainian Ophthalmology
- Vol. 14 (2) , 117-124
Open AccessFeatures of vitreoretinal surgery for idiopathic epiretinal membranes
Background. Idiopathic epiretinal membranes (ERM) are among the most common disorders of the vitreomacular interface and are one of the leading causes of reduced central vision in older patients. According to recent studies, the prevalence of ERM ranges from 7 to 39 %. With the aging of the population, the number of patients with symptomatic ERMs continues to increase, highlighting the high medical and social significance of this condition and the need to improve current treatments. Objective: to investigate the efficacy of contemporary combined and two-stage surgical approaches for the treatment of epiretinal membranes associated with age-related cataract. Materials and methods. The study included 150 patients (150 eyes) with ERM and initial age-related cataract, who were divided into two study groups. The mean age of the participants was 61.0 ± 2.3 years. In group 1 (81 eyes), 25-gauge closed subtotal vitrectomy (CSV) with ERM peeling was performed, followed by phacoemulsification 3 months later. In group 2 (69 eyes), CSV with combined ERM/internal limiting membrane (ILM) peeling was performed simultaneously with phacoemulsification and intraocular lens implantation. All patients underwent optical coherence tomography of the macular region, which was used to determine central retinal thickness, assess morphological changes in the macula, and detect the presence of an epiretinal membrane. Examinations were performed before surgery and at 1, 3, 6, and 12 months postoperatively. Results. Phacoemulsification in combination with vitreoretinal surgery is associated with a higher incidence of macular edema in the early postoperative period. However, these changes were transient; their incidence decreased significantly after 3 months, and at one year, clinically significant macular edema was absent in all patients, regardless of the type of surgical intervention. This indicates a favorable long-term prognosis for both surgical approaches. Conclusions. Our studies demonstrated that CSV with ERM peeling only and CSV with combined ERM/ILM peeling, performed either without or with simultaneous cataract surgery, are effective methods for the treatment of ERM and result in improved visual function over a 1-year follow-up period. Phacoemulsification did not significantly improve visual acuity and, conversely, was associated with a higher incidence of persistent macular edema at 1 and 3 months postoperatively. ILM peeling did not improve functional outcomes after ERM surgery but reduced the risk of ERM recurrence.
- Open Access
- 29 September 2025
- Published by Publishing House Zaslavsky in Archive of Ukrainian Ophthalmology
- Vol. 13 (3) , 172-178
Study of plasma vitamin D3 concentration as a modulator of lipid profile, inflammation and neurodegeneration in diabetic retinopathy in type 2 diabetes mellitus
Background. Vitamin D3 as a multifunctional biological agent actively participates in the pathogenesis of diabetic retinopathy (DR) in type 2 diabetes mellitus (T2DM), which allows researchers to consider it a potential biomarker for assessing patient status. We aimed to examine plasma vitamin D3 concentrations in patients with DR associated with T2DM and to analyze their correlations with parameters of inflammation, lipid metabolism, and neurodegeneration to identify new biomarkers. Materials and methods. We enrolled 106 patients (106 eyes) diagnosed with DR on the background of T2DM and divided them into subgroups according to the ETDRS severity scale. The study design included 3 groups: patients with non-proliferative DR (level 47–53e), moderate proliferative DR (level 61–75), and advanced proliferative DR (level 81–85). The control group included 64 relatively healthy individuals matched by age and sex. Plasma concentrations of vitamin D3, interleukin (IL) 1β, IL-10, ferritin, homocysteine, and non-neuronal enolase (NNE) were measured using enzyme-linked immunosorbent assay, and lipid profiles were analyzed. Statistical analysis was performed using IBM SPSS Statistics 23 and MedStat programs. Results. Patients with DR and vitamin D3 deficiency on the background of T2DM showed clear signs of chronic systemic inflammation and a relationship with NNE concentration, indicating more pronounced low-grade microglial inflammation in the brain and retina, a key mechanism underlying neurodegeneration and associated vision loss. This cohort also had a significant correlation between ferritin and IL-10 levels, but not IL-1β, which supports a differentiated approach to monitoring chronic systemic inflammation. Patients with advanced proliferative DR demonstrated significantly lower vitamin D3 levels if they were not receiving statin therapy. Conclusions. Plasma vitamin D3 concentration in patients with DR associated with T2DM serves as a biomarker for assessing neurodegeneration, systemic inflammation, and clinical outcomes, providing a basis for individualized patient management and DR prognosis. Statin therapy helps achieve stable compensation of vitamin D3 deficiency.
- 29 September 2025
- Published by Publishing House Zaslavsky in Archive of Ukrainian Ophthalmology
- Vol. 13 (3) , 172-178
Open AccessStudy of plasma vitamin D3 concentration as a modulator of lipid profile, inflammation and neurodegeneration in diabetic retinopathy in type 2 diabetes mellitus
Background. Vitamin D3 as a multifunctional biological agent actively participates in the pathogenesis of diabetic retinopathy (DR) in type 2 diabetes mellitus (T2DM), which allows researchers to consider it a potential biomarker for assessing patient status. We aimed to examine plasma vitamin D3 concentrations in patients with DR associated with T2DM and to analyze their correlations with parameters of inflammation, lipid metabolism, and neurodegeneration to identify new biomarkers. Materials and methods. We enrolled 106 patients (106 eyes) diagnosed with DR on the background of T2DM and divided them into subgroups according to the ETDRS severity scale. The study design included 3 groups: patients with non-proliferative DR (level 47–53e), moderate proliferative DR (level 61–75), and advanced proliferative DR (level 81–85). The control group included 64 relatively healthy individuals matched by age and sex. Plasma concentrations of vitamin D3, interleukin (IL) 1β, IL-10, ferritin, homocysteine, and non-neuronal enolase (NNE) were measured using enzyme-linked immunosorbent assay, and lipid profiles were analyzed. Statistical analysis was performed using IBM SPSS Statistics 23 and MedStat programs. Results. Patients with DR and vitamin D3 deficiency on the background of T2DM showed clear signs of chronic systemic inflammation and a relationship with NNE concentration, indicating more pronounced low-grade microglial inflammation in the brain and retina, a key mechanism underlying neurodegeneration and associated vision loss. This cohort also had a significant correlation between ferritin and IL-10 levels, but not IL-1β, which supports a differentiated approach to monitoring chronic systemic inflammation. Patients with advanced proliferative DR demonstrated significantly lower vitamin D3 levels if they were not receiving statin therapy. Conclusions. Plasma vitamin D3 concentration in patients with DR associated with T2DM serves as a biomarker for assessing neurodegeneration, systemic inflammation, and clinical outcomes, providing a basis for individualized patient management and DR prognosis. Statin therapy helps achieve stable compensation of vitamin D3 deficiency.
- Open Access
- 25 May 2025
- Published by Publishing House Zaslavsky in Archive of Ukrainian Ophthalmology
- Vol. 13 (1) , 1-5
Systemic risk factors for progression of diabetic retinopathy in type 2 diabetes mellitus
Background. According to the International Diabetes Federation (IDF), the number of adults with diabetes mellitus worldwide reached 537 million in 2021, which is 9.8 % of the world’s population. In Ukraine, according to the IDF, the number of patients with diabetes was 2.35 million people in 2021. It is known that diabetic retinopathy is one of the most severe vascular complications of diabetes and the main cause of blindness, affecting about 40 % of patients. The purpose was to establish the most significant systemic risk factors for the progression of diabetic retinopathy in type 2 diabetes. Materials and methods. An analytical prospective cohort study was conducted with a total of 186 people with type 2 diabetes from the Ukrainian population. They were divided into the following groups according to the condition of the worse eye: the main group — any form of diabetic retinopathy (112 people) and the comparison group — no signs of diabetic retinopathy (74 patients). The inclusion criteria were voluntary informed consent to participate in the study, age over 18 years, presence of verified type 2 diabetes. The type of glucose-lowering therapy was prescribed by an endocrinologist. All patients underwent a standard ophthalmological examination (visometry, refractometry, intraocular pressure and visual field test, gonioscopy, biomicroscopy, ophthalmoscopy, optical coherence tomography, fundus photography). Systemic factors included were blood pressure — systolic and diastolic, glycosylated hemoglobin, blood ferritin and hemoglobin, cholesterol and low-density lipoprotein levels. Statistical analysis of the study results was performed using the licensed software package Statistica v6.1. Results. Most patients with type 2 diabetes in the main group (75.89 %) were diagnosed with a severe form of disease compared to 29.72 % of controls (p < 0.01). Accordingly, 69.64 % of patients in the main group and only 43.24 % of patients with diabetes without manifestations of retinopathy were on insulin therapy (p < 0.05). It was found that the level of glycosylated hemoglobin in the main group was significantly higher than in controls: 8.64 ± 0.62 % versus 6.90 ± 0.21 % (p < 0.05). The levels of hemoglobin, ferritin and cholesterol in the main group were statistically significantly higher than in the control one (p < 0.05). Low-density lipoprotein level did not have a statistically significant difference in both groups (p > 0.05); however, in the main group, the indicator was higher than in controls. Conclusions. The occurrence of diabetic retinopathy depends on the severity of type 2 diabetes. According to our data, 75.89 % of patients with diabetic retinopathy of various stages were diagnosed with a severe form of diabetes compared to 29.72 % of those without manifestations of diabetic retinopathy (p < 0.01). Systemic risk factors for diabetic retinopathy include elevated levels of glycosylated hemoglobin, ferritin, hemoglobin, and blood cholesterol (p < 0.05).
- 25 May 2025
- Published by Publishing House Zaslavsky in Archive of Ukrainian Ophthalmology
- Vol. 13 (1) , 1-5
Open AccessSystemic risk factors for progression of diabetic retinopathy in type 2 diabetes mellitus
Background. According to the International Diabetes Federation (IDF), the number of adults with diabetes mellitus worldwide reached 537 million in 2021, which is 9.8 % of the world’s population. In Ukraine, according to the IDF, the number of patients with diabetes was 2.35 million people in 2021. It is known that diabetic retinopathy is one of the most severe vascular complications of diabetes and the main cause of blindness, affecting about 40 % of patients. The purpose was to establish the most significant systemic risk factors for the progression of diabetic retinopathy in type 2 diabetes. Materials and methods. An analytical prospective cohort study was conducted with a total of 186 people with type 2 diabetes from the Ukrainian population. They were divided into the following groups according to the condition of the worse eye: the main group — any form of diabetic retinopathy (112 people) and the comparison group — no signs of diabetic retinopathy (74 patients). The inclusion criteria were voluntary informed consent to participate in the study, age over 18 years, presence of verified type 2 diabetes. The type of glucose-lowering therapy was prescribed by an endocrinologist. All patients underwent a standard ophthalmological examination (visometry, refractometry, intraocular pressure and visual field test, gonioscopy, biomicroscopy, ophthalmoscopy, optical coherence tomography, fundus photography). Systemic factors included were blood pressure — systolic and diastolic, glycosylated hemoglobin, blood ferritin and hemoglobin, cholesterol and low-density lipoprotein levels. Statistical analysis of the study results was performed using the licensed software package Statistica v6.1. Results. Most patients with type 2 diabetes in the main group (75.89 %) were diagnosed with a severe form of disease compared to 29.72 % of controls (p < 0.01). Accordingly, 69.64 % of patients in the main group and only 43.24 % of patients with diabetes without manifestations of retinopathy were on insulin therapy (p < 0.05). It was found that the level of glycosylated hemoglobin in the main group was significantly higher than in controls: 8.64 ± 0.62 % versus 6.90 ± 0.21 % (p < 0.05). The levels of hemoglobin, ferritin and cholesterol in the main group were statistically significantly higher than in the control one (p < 0.05). Low-density lipoprotein level did not have a statistically significant difference in both groups (p > 0.05); however, in the main group, the indicator was higher than in controls. Conclusions. The occurrence of diabetic retinopathy depends on the severity of type 2 diabetes. According to our data, 75.89 % of patients with diabetic retinopathy of various stages were diagnosed with a severe form of diabetes compared to 29.72 % of those without manifestations of diabetic retinopathy (p < 0.01). Systemic risk factors for diabetic retinopathy include elevated levels of glycosylated hemoglobin, ferritin, hemoglobin, and blood cholesterol (p < 0.05).
- Open Access
- 25 May 2025
- Published by Publishing House Zaslavsky in Archive of Ukrainian Ophthalmology
- Vol. 13 (1) , 63-67
Specifics of teaching the topic “Ocular changes in diabetes mellitus: classification, etiology, pathogenesis, risk factors. Algorithm for early diagnosis” under wartime conditions
Background. Unfortunately, on February 24, 2022, a full-scale invasion of Ukraine by the aggressor country took place. This event significantly changed all the realities of modern life, even affected the teaching of special disciplines in postgraduate education institutions. The traditional approach to teaching the topic “Ocular changes in diabetes mellitus: classification, etiology, pathogenesis, risk factors. Algorithm for early diagnosis” requires adaptation to modern realities, in particular the integration of the latest technologies, such as telemedicine and mobile applications for monitoring the state of patients. The purpose was to develop recommendations for teaching the topic “Ocular changes in diabetes mellitus: classification, etiology, pathogenesis, risk factors. Algorithm for early diagnosis” in wartime conditions. Material and methods. Data from relevant Internet resources and modern literature on the problem under study were analyzed, as well as personal experience and developments in teaching by employees of the Department of Ophthalmology of the Shupyk National Healthcare University of Ukraine. Results. Diabetic retinopathy, glaucoma and cataract are the main ophthalmic complications that significantly worsen the quality of life of patients with diabetes mellitus types 1 and 2, and in some cases lead to complete vision loss. At the same time, in the early stages, these complications can be almost asymptomatic, which makes their detection and treatment even more difficult. It is necessary to draw the attention of interns and trainee doctors to the fact that it is very important for patients with diabetes to constantly visit a doctor who will monitor the course of the disease and help control glucose levels to prevent complications. In our opinion, the greatest burden in teaching is carried by online learning and the creation of new, modern printed or online guidelines. Young specialists should pay attention to the use of accessible methods for diagnosis and treatment of patients with diabetic and diabetes mellitus, because from a socio-economic and medical point of view, the diagnosis of diabetes mellitus and its complications, such as diabetic retinopathy, implies an economic burden not only on the state, but also on the patient themselves and their family. Conclusions. Particular attention should be paid to clear regulation of the work of educational institutions under armed conflict, as well as a review of approaches to the organization of the educational process and practical training of students, interns and trainee doctors, which will ensure the continuity and quality of education even in wartime. Teaching the topic “Ocular changes in diabetes mellitus: classification, etiology, pathogenesis, risk factors. Algorithm for early diagnosis” remains relevant during war. Modern innovative teaching methods cannot always be used in the system of postgraduate education of doctors in wartime. The main direction of improving teaching is online learning, the use of artificial intelligence, the development of a combination of different forms of education and the creation of printed and online modern methodological literature.
- 25 May 2025
- Published by Publishing House Zaslavsky in Archive of Ukrainian Ophthalmology
- Vol. 13 (1) , 63-67
Open AccessSpecifics of teaching the topic “Ocular changes in diabetes mellitus: classification, etiology, pathogenesis, risk factors. Algorithm for early diagnosis” under wartime conditions
Background. Unfortunately, on February 24, 2022, a full-scale invasion of Ukraine by the aggressor country took place. This event significantly changed all the realities of modern life, even affected the teaching of special disciplines in postgraduate education institutions. The traditional approach to teaching the topic “Ocular changes in diabetes mellitus: classification, etiology, pathogenesis, risk factors. Algorithm for early diagnosis” requires adaptation to modern realities, in particular the integration of the latest technologies, such as telemedicine and mobile applications for monitoring the state of patients. The purpose was to develop recommendations for teaching the topic “Ocular changes in diabetes mellitus: classification, etiology, pathogenesis, risk factors. Algorithm for early diagnosis” in wartime conditions. Material and methods. Data from relevant Internet resources and modern literature on the problem under study were analyzed, as well as personal experience and developments in teaching by employees of the Department of Ophthalmology of the Shupyk National Healthcare University of Ukraine. Results. Diabetic retinopathy, glaucoma and cataract are the main ophthalmic complications that significantly worsen the quality of life of patients with diabetes mellitus types 1 and 2, and in some cases lead to complete vision loss. At the same time, in the early stages, these complications can be almost asymptomatic, which makes their detection and treatment even more difficult. It is necessary to draw the attention of interns and trainee doctors to the fact that it is very important for patients with diabetes to constantly visit a doctor who will monitor the course of the disease and help control glucose levels to prevent complications. In our opinion, the greatest burden in teaching is carried by online learning and the creation of new, modern printed or online guidelines. Young specialists should pay attention to the use of accessible methods for diagnosis and treatment of patients with diabetic and diabetes mellitus, because from a socio-economic and medical point of view, the diagnosis of diabetes mellitus and its complications, such as diabetic retinopathy, implies an economic burden not only on the state, but also on the patient themselves and their family. Conclusions. Particular attention should be paid to clear regulation of the work of educational institutions under armed conflict, as well as a review of approaches to the organization of the educational process and practical training of students, interns and trainee doctors, which will ensure the continuity and quality of education even in wartime. Teaching the topic “Ocular changes in diabetes mellitus: classification, etiology, pathogenesis, risk factors. Algorithm for early diagnosis” remains relevant during war. Modern innovative teaching methods cannot always be used in the system of postgraduate education of doctors in wartime. The main direction of improving teaching is online learning, the use of artificial intelligence, the development of a combination of different forms of education and the creation of printed and online modern methodological literature.
- Open Access
- 30 December 2024
- Published by Publishing House Zaslavsky in Archive of Ukrainian Ophthalmology
- Vol. 12 (3) , 205-210
Peculiarities of morphological changes in the lamina cribrosa in patients with myopia and options of drug influence on its state
The literature review substantiates the need to study the morphological changes in the lamina cribrosa in patients with myopia. The authors discuss the pathogenesis of axial myopia, namely, changes in the lamina cribrosa in pathological elongation of the anteroposterior axis of the eye. It is interesting to review the methods for the treatment and diagnosis of myopia, which remain extremely difficult tasks due to the lack of knowledge about most pathogenetic mechanisms of its development. The authors mention the commonly available and well-known spectra of treatment measures: conservative, surgical, laser methods of treatment and diagnosis of myopia, as well as modern drug regimens to control the progression of myopic changes. To date, there are quite a few studies on changes in the lamina cribrosa in glaucoma. However, research on the parameters of lamina cribrosa changes in myopia is rare in scientific literature. A modern approach to the diagnosis of changes in the lamina cribrosa will help clarify the mechanisms of visual impairment in these patients and will serve as the basis for the development of methods for the prevention and treatment of blindness in people suffering from myopia.
- 30 December 2024
- Published by Publishing House Zaslavsky in Archive of Ukrainian Ophthalmology
- Vol. 12 (3) , 205-210
Open AccessPeculiarities of morphological changes in the lamina cribrosa in patients with myopia and options of drug influence on its state
The literature review substantiates the need to study the morphological changes in the lamina cribrosa in patients with myopia. The authors discuss the pathogenesis of axial myopia, namely, changes in the lamina cribrosa in pathological elongation of the anteroposterior axis of the eye. It is interesting to review the methods for the treatment and diagnosis of myopia, which remain extremely difficult tasks due to the lack of knowledge about most pathogenetic mechanisms of its development. The authors mention the commonly available and well-known spectra of treatment measures: conservative, surgical, laser methods of treatment and diagnosis of myopia, as well as modern drug regimens to control the progression of myopic changes. To date, there are quite a few studies on changes in the lamina cribrosa in glaucoma. However, research on the parameters of lamina cribrosa changes in myopia is rare in scientific literature. A modern approach to the diagnosis of changes in the lamina cribrosa will help clarify the mechanisms of visual impairment in these patients and will serve as the basis for the development of methods for the prevention and treatment of blindness in people suffering from myopia.
- Open Access
- 30 December 2024
- Published by Publishing House Zaslavsky in Archive of Ukrainian Ophthalmology
- Vol. 12 (3) , 137-142
Peculiarities of morphofunctional changes of the eye and lamina cribrosa in myopia of various degrees: final report
Background. Myopia is the most common visual defect. Complicated myopia is one of the main causes of disability due to eye diseases. In case of myopia, the axial length increases, and all membranes are loosened. Lamina cribrosa (LC) undergoes special changes. Clinical assessment of the LC parameters has high diagnostic significance. LC defects, changes in its thickness and depth of location can be well visualized using modern research methods, and therefore, allow us to study these parameters in detail in the norm and with the development of eye pathology. The correlation between the optic disc deformation and LC deformation and its pores remains unknown. It is only known that the severity of the lesion will depend on the degree of damage to the nerve and ganglion fibers and the degree of change in the LC structure. The purpose: to study the features of morphofunctional changes in the eye and lamina cribrosa in myopia of various degrees based on the analysis of morphological and morphometric parameters. Materials and methods. The study consisted of experimental and clinical parts. During the experiment, 42 animals (rabbits) (84 eyes) were studied. A comprehensive diagnostic examination of 120 people (230 eyes) was conducted. The control group included 20 patients without myopia (40 eyes). All patients were of working age, from 18 to 45 years. Patients in the main group received a vitamin complex containing carotenoids, lutein, zeaxanthin and omega-3 fatty acids, as well as vitamin B preparation. The control group did not receive treatment. Results. When studying the optic disc parameters in patients with different degrees of myopia, the most significant changes occurred in the indicators of GLV, nerve head, optic disc area. The parameters of MD and PSD perimetry differed significantly in all groups. Based on the developed markers, with the help of optical coherence tomography, it was possible to assess the general morphology and position of the LC in patients by measuring its depth and insertion in different meridians. After treatment of patients, statistically significant positive dynamics was revealed, taking into account changes in the indicators of Humphrey perimetry — MD and PSD, as well as a tendency to improve visual acuity, the absence of significant changes in the anterior-posterior segment of the eye, intraocular pressure, average refraction in the main group during the entire treatment period without significant statistical changes. The experimental study on the effect of low doses of atropine revealed the appearance of functionally active fibroblasts with the accumulation of the ground substance and thickening of the bundles of collagen fibers of the sclera and the walls of the LC pores, which is accompanied by thickening of both the sclera and the LC when using 0.5 and 0.01% atropine sulfate solution compared to the control group. Conclusions. LC defects, changes in its thickness and depth of location are well visualized using optical coherence tomography. With the experimental use of 0.01% atropine sulfate, strengthening of the sclera and LC with preservation of the morphofunctional state of the receptor apparatus of the eye was proven, which allows us to consider it advisable to use the selected concentration of the drug in the future in patients with myopia.
- 30 December 2024
- Published by Publishing House Zaslavsky in Archive of Ukrainian Ophthalmology
- Vol. 12 (3) , 137-142
Open AccessPeculiarities of morphofunctional changes of the eye and lamina cribrosa in myopia of various degrees: final report
Background. Myopia is the most common visual defect. Complicated myopia is one of the main causes of disability due to eye diseases. In case of myopia, the axial length increases, and all membranes are loosened. Lamina cribrosa (LC) undergoes special changes. Clinical assessment of the LC parameters has high diagnostic significance. LC defects, changes in its thickness and depth of location can be well visualized using modern research methods, and therefore, allow us to study these parameters in detail in the norm and with the development of eye pathology. The correlation between the optic disc deformation and LC deformation and its pores remains unknown. It is only known that the severity of the lesion will depend on the degree of damage to the nerve and ganglion fibers and the degree of change in the LC structure. The purpose: to study the features of morphofunctional changes in the eye and lamina cribrosa in myopia of various degrees based on the analysis of morphological and morphometric parameters. Materials and methods. The study consisted of experimental and clinical parts. During the experiment, 42 animals (rabbits) (84 eyes) were studied. A comprehensive diagnostic examination of 120 people (230 eyes) was conducted. The control group included 20 patients without myopia (40 eyes). All patients were of working age, from 18 to 45 years. Patients in the main group received a vitamin complex containing carotenoids, lutein, zeaxanthin and omega-3 fatty acids, as well as vitamin B preparation. The control group did not receive treatment. Results. When studying the optic disc parameters in patients with different degrees of myopia, the most significant changes occurred in the indicators of GLV, nerve head, optic disc area. The parameters of MD and PSD perimetry differed significantly in all groups. Based on the developed markers, with the help of optical coherence tomography, it was possible to assess the general morphology and position of the LC in patients by measuring its depth and insertion in different meridians. After treatment of patients, statistically significant positive dynamics was revealed, taking into account changes in the indicators of Humphrey perimetry — MD and PSD, as well as a tendency to improve visual acuity, the absence of significant changes in the anterior-posterior segment of the eye, intraocular pressure, average refraction in the main group during the entire treatment period without significant statistical changes. The experimental study on the effect of low doses of atropine revealed the appearance of functionally active fibroblasts with the accumulation of the ground substance and thickening of the bundles of collagen fibers of the sclera and the walls of the LC pores, which is accompanied by thickening of both the sclera and the LC when using 0.5 and 0.01% atropine sulfate solution compared to the control group. Conclusions. LC defects, changes in its thickness and depth of location are well visualized using optical coherence tomography. With the experimental use of 0.01% atropine sulfate, strengthening of the sclera and LC with preservation of the morphofunctional state of the receptor apparatus of the eye was proven, which allows us to consider it advisable to use the selected concentration of the drug in the future in patients with myopia.
- Open Access
- 30 June 2023
- Published by Bogomolets National Medical University in Medical Science of Ukraine (MSU)
- Vol. 19 (2) , 49-57
PATHOGENETICALLY DIRECTED METHOD OF PREVENTION AND TREATMENT OF AGE-MACULAR DEGENERATION
Background. Age-related macular degeneration is one of the most common causes of blindness in developed countries, especially in people over 60 years old. The incidence of AMD is projected to increase to 288 million in 2040 compared to 196 million in 2020. Cardiovascular factors, smoking, alcohol consumption, overweight, genetic factors, and metabolic disorders are risk factors for the development of AMD. There are disorders of lipid metabolism, as well as hyperreactivity of platelet purine receptors may be associated with the progression of AMD. The AREDS2 formula is currently used to treat AMD. New therapeutic strategies aimed to correct metabolic disorders are needed to decrease the development of the late stages of AMD. Aim: to investigate the effectiveness of improving pathogenetically directed method of prevention and treatment of age-related macular degeneration. Materials and methods. We observed 40 patients (80 eyes), aged 50-85 years, with AMD of category 3 (intermediate AMD), who were divided into 2 groups. The main group included 20 patients (40 eyes), 14 women and 6 men, who have prescribed a complex drug according to the standard AREDS2 scheme, as well as fenofibrate (200 mg) and clopidogrel bisulfate (75 mg). The control group included 20 patients (40 eyes), 13 women and 7 men. These patients received AREDS2 standard treatment. Progression was evaluated according to the results of OCT of the macular area according to the AREDS classification and control of corrected visual acuity (CVA). The observation period was 2 years. Results. No signs of progression were noted in patients of both observation groups within 6 months from the start of the prescribed therapy. In the patients of the control group, the progression of the disease was recorded after 1 year of observation according to both defined criteria. Changes in OCT were observed in 7,5% of patients in the control group, and a decrease in CVA- in 5%. In the patients of the main group who used the extended therapeutic regimen, after 1 year of follow-up, progression according to OCT signs was noted in 2,5% of cases, but there was no worsening of CVA. After 2 years of observation, signs of progression according to OST were recorded in the main group by 50% less than in the control group. According to CVA, disease progression was detected in 15% of the main group and 30% of the control group. Conclusions. This study complemented already existing therapeutic strategies for the preventive treatment of AMD. Актуальність. Вікова макулярна дегенерація – одна з найпоширеніших причин сліпоти в розвинених країнах, особливо у людей старше 60 років. Прогнозується збільшення захворюваності на ВМД до 288 мільйонів у 2040 році порівняно з 196 мільйонами у 2020 році. Серцево-судинні фактори, куріння, вживання алкоголю, надмірна вага, генетичні чинники, метаболічні порушеннями є факторами ризику розвитку ВМД. Серед метаболічних факторів, що можуть бути пов’язані з прогресуванням ВМД, визначають порушення ліпідного обміну, а також гіперреактивність пуринових рецепторів тромбоцитів. Для лікування ВМД зараз застосовують формулу AREDS2. Необхідні нові терапевтичні стратегії, спрямовані на корекцію метаболічних порушень для уповільння розвитку пізніх стадій ВМД. Ціль: дослідити ефективність вдосконаленого патогенетично спрямованого методу профілактики і лікування вікової макулярної дегенерації. Матеріали та методи. Спостерігали за 40 пацієнтами (80 очей), віком 50-85 років, з ВМД 3 категорії (проміжна ВМД), яких було поділено на 2 групи. До основної групи увійшли 20 пацієнтів (40 очей) 14 жінок і 6 чоловіків, яким було призначено комплексний препарат за стандартною схемою AREDS2, а також фенофібрат (200 мг) і клопідогрелю бісульфат (75 мг). Групу контролю склали 20 пацієнтів (40 очей) -13 жінок і 7 чоловіків. Цим пацієнтам призначали стандартне лікування за AREDS2. Прогресування оцінювалось за результатами ОСТ макулярної ділянки за класифікацією AREDS та контролем МКГЗ. Термін спостереження – 2 роки. Результати. У пацієнтів обох груп спостереження протягом 6 місяців від початку призначеної терапії не було відмічено ознак прогресування. У пацієнтів групи контролю прогресування захворювання було зафіксоване через 1 рік спостереження за обома визначеними критеріями. Зміни на ОСТ спостерігались у 7,5% пацієнтів групи контролю, а зниження МКГЗ - у 5%. У пацієнтів основної групи, які застосовували розширену терапевтичну схему,...
- 30 June 2023
- Published by Bogomolets National Medical University in Medical Science of Ukraine (MSU)
- Vol. 19 (2) , 49-57
Open AccessPATHOGENETICALLY DIRECTED METHOD OF PREVENTION AND TREATMENT OF AGE-MACULAR DEGENERATION
Background. Age-related macular degeneration is one of the most common causes of blindness in developed countries, especially in people over 60 years old. The incidence of AMD is projected to increase to 288 million in 2040 compared to 196 million in 2020. Cardiovascular factors, smoking, alcohol consumption, overweight, genetic factors, and metabolic disorders are risk factors for the development of AMD. There are disorders of lipid metabolism, as well as hyperreactivity of platelet purine receptors may be associated with the progression of AMD. The AREDS2 formula is currently used to treat AMD. New therapeutic strategies aimed to correct metabolic disorders are needed to decrease the development of the late stages of AMD. Aim: to investigate the effectiveness of improving pathogenetically directed method of prevention and treatment of age-related macular degeneration. Materials and methods. We observed 40 patients (80 eyes), aged 50-85 years, with AMD of category 3 (intermediate AMD), who were divided into 2 groups. The main group included 20 patients (40 eyes), 14 women and 6 men, who have prescribed a complex drug according to the standard AREDS2 scheme, as well as fenofibrate (200 mg) and clopidogrel bisulfate (75 mg). The control group included 20 patients (40 eyes), 13 women and 7 men. These patients received AREDS2 standard treatment. Progression was evaluated according to the results of OCT of the macular area according to the AREDS classification and control of corrected visual acuity (CVA). The observation period was 2 years. Results. No signs of progression were noted in patients of both observation groups within 6 months from the start of the prescribed therapy. In the patients of the control group, the progression of the disease was recorded after 1 year of observation according to both defined criteria. Changes in OCT were observed in 7,5% of patients in the control group, and a decrease in CVA- in 5%. In the patients of the main group who used the extended therapeutic regimen, after 1 year of follow-up, progression according to OCT signs was noted in 2,5% of cases, but there was no worsening of CVA. After 2 years of observation, signs of progression according to OST were recorded in the main group by 50% less than in the control group. According to CVA, disease progression was detected in 15% of the main group and 30% of the control group. Conclusions. This study complemented already existing therapeutic strategies for the preventive treatment of AMD. Актуальність. Вікова макулярна дегенерація – одна з найпоширеніших причин сліпоти в розвинених країнах, особливо у людей старше 60 років. Прогнозується збільшення захворюваності на ВМД до 288 мільйонів у 2040 році порівняно з 196 мільйонами у 2020 році. Серцево-судинні фактори, куріння, вживання алкоголю, надмірна вага, генетичні чинники, метаболічні порушеннями є факторами ризику розвитку ВМД. Серед метаболічних факторів, що можуть бути пов’язані з прогресуванням ВМД, визначають порушення ліпідного обміну, а також гіперреактивність пуринових рецепторів тромбоцитів. Для лікування ВМД зараз застосовують формулу AREDS2. Необхідні нові терапевтичні стратегії, спрямовані на корекцію метаболічних порушень для уповільння розвитку пізніх стадій ВМД. Ціль: дослідити ефективність вдосконаленого патогенетично спрямованого методу профілактики і лікування вікової макулярної дегенерації. Матеріали та методи. Спостерігали за 40 пацієнтами (80 очей), віком 50-85 років, з ВМД 3 категорії (проміжна ВМД), яких було поділено на 2 групи. До основної групи увійшли 20 пацієнтів (40 очей) 14 жінок і 6 чоловіків, яким було призначено комплексний препарат за стандартною схемою AREDS2, а також фенофібрат (200 мг) і клопідогрелю бісульфат (75 мг). Групу контролю склали 20 пацієнтів (40 очей) -13 жінок і 7 чоловіків. Цим пацієнтам призначали стандартне лікування за AREDS2. Прогресування оцінювалось за результатами ОСТ макулярної ділянки за класифікацією AREDS та контролем МКГЗ. Термін спостереження – 2 роки. Результати. У пацієнтів обох груп спостереження протягом 6 місяців від початку призначеної терапії не було відмічено ознак прогресування. У пацієнтів групи контролю прогресування захворювання було зафіксоване через 1 рік спостереження за обома визначеними критеріями. Зміни на ОСТ спостерігались у 7,5% пацієнтів групи контролю, а зниження МКГЗ - у 5%. У пацієнтів основної групи, які застосовували розширену терапевтичну схему,...